For: | Lino-Silva LS, Gamboa-Domínguez A, Zúñiga-Tamayo D, Salcedo-Hernández RA, Cetina L, Cantú-de-León D. Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study. World J Clin Oncol 2018; 9(7): 133-139 [PMID: 30425938 DOI: 10.5306/wjco.v9.i7.133] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v9/i7/133.htm |
Number | Citing Articles |
1 |
Pantea Pour Farid, Markus Eckstein, Susanne Merkel, Robert Grützmann, Arndt Hartmann, Volker Bruns, Michaela Benz, Regine Schneider-Stock, Carol I. Geppert. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. International Journal of Molecular Sciences 2021; 22(23): 13108 doi: 10.3390/ijms222313108
|
2 |
E. O'Connell, I.S. Reynolds, D.A. McNamara, J.H.M. Prehn, J.P. Burke. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis. Surgical Oncology 2020; 34: 57 doi: 10.1016/j.suronc.2020.03.009
|
3 |
Alessandro Lugli, Inti Zlobec, Martin D. Berger, Richard Kirsch, Iris D. Nagtegaal. Tumour budding in solid cancers. Nature Reviews Clinical Oncology 2021; 18(2): 101 doi: 10.1038/s41571-020-0422-y
|
4 |
Sonay Kus Öztürk, Tariq S. Haddad, Inti Zlobec, Alessandro Lugli, Iris D. Nagtegaal. Attackers and defenders: tumor buds and lymphocytes as morphological biomarkers in colorectal cancer. Diagnostic Histopathology 2022; 28(11): 480 doi: 10.1016/j.mpdhp.2022.08.002
|
5 |
Inti Zlobec, Martin D. Berger, Alessandro Lugli. Tumour budding and its clinical implications in gastrointestinal cancers. British Journal of Cancer 2020; 123(5): 700 doi: 10.1038/s41416-020-0954-z
|
6 |
Yuho Ono, Justin M.M. Cates, Raul S. Gonzalez. Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?. Pathology - Research and Practice 2021; 226: 153608 doi: 10.1016/j.prp.2021.153608
|
7 |
Felix Müller, Alessandro Lugli, Heather Dawson. Tumor Budding beim kolorektalen Karzinom – Informationen zur klinischen Anwendung und Anleitung zur praktischen Bestimmung. Der Pathologe 2022; 43(1): 45 doi: 10.1007/s00292-021-01016-6
|
8 |
Serena Ammendola, Nicolò Caldonazzi, Paola Chiara Rizzo, Giulia Turri, Corrado Pedrazzani, Valeria Barresi. H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma. Biomedicines 2022; 10(8): 2042 doi: 10.3390/biomedicines10082042
|
9 |
Sonay Kuş Öztürk, John-Melle Bokhorst, Elias Baumann, Kieran Sheahan, Cornelis J.H. van de Velde, Corrie A.M. Marijnen, Geke A.P. Hospers, Michail Doukas, Michael Vieth, Alessandro Lugli, Iris D. Nagtegaal. Exploring intratumoral budding in colorectal cancer using computational pathology: a biopsy- based evaluation. Modern Pathology 2024; : 100655 doi: 10.1016/j.modpat.2024.100655
|
10 |
Hui Jiang, Yelin Yang, Yuping Qian, Chengwei Shao, Jianping Lu, Yun Bian, Jianming Zheng. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740212
|
11 |
Annika Blank, Carla Schenker, Heather Dawson, Guido Beldi, Inti Zlobec, Alessandro Lugli. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00247
|
12 |
Sara Cherri, Ester Oneda, Silvia Noventa, Laura Melocchi, Alberto Zaniboni. Microsatellite instability and chemosensitivity in solid tumours. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221099347
|
13 |
Shehara Mendis, Yat Hang To, Jeanne Tie. Biomarkers in Locally Advanced Rectal Cancer: A Review. Clinical Colorectal Cancer 2022; 21(1): 36 doi: 10.1016/j.clcc.2021.11.002
|